From the Literature

  • PDF / 124,001 Bytes
  • 7 Pages / 612.28 x 790.87 pts Page_size
  • 80 Downloads / 212 Views

DOWNLOAD

REPORT

NEWS

ª 2009 Adis Data Information BV. All rights reserved.

From the Literature Case ReportsContents 1. Antiallergics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269 2. Antineoplastics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269 3. Antivirals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271 4. Cardiovascular Therapies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272 5. Immunosuppressants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273 6. Neurologic and Psychiatric Therapies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273 7. News . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275

1. Antiallergics Hydroxyzine: Syncope, QT-Interval Prolongation, and Torsade de Pointes: Case Report

A 34-year-old woman developed syncope, QT-interval prolongation, and torsade de pointes during treatment with hydroxyzine for chronic pruligo [sic]. The woman started receiving hydroxyzine 75 mg/day and, 3 days later, developed repetitive syncope and was admitted to hospital; she had a history of presyncopal attack of unknown origin. On admission, an ECG showed a QT-interval prolongation of 640 ms (QTc 630 ms). Her syncope was suspected to be related to torsade de pointes. Hydroxyzine was discontinued on admission. She experienced no further syncope. Three weeks after the episode, her QT interval had gradually shortened to 460 ms (QTc 464 ms). A drug-induced extreme prolongation of the QT interval was considered likely. Subsequent genetic testing revealed that she had a heterozygous A614-human ether-a-go-go-related gene (HERG) mutation. Author comment: ‘‘In our patient, both genetic background and female sex are definite risk factors to trigger QT prolongation. In addition, hydroxyzine intake produced a ‘‘double hit’’, leading to a reduction in cardiac ‘‘repolarization reserve’’ and a severe phenotype, presumably [torsade de pointes].’’

Sakaguchi T, Itoh H, Ding W-G, et al. Hydroxyzine, a first generation H1-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutati

Data Loading...

Recommend Documents
From the Literature

175 1 112KB

From the Literature

158 40 113KB

From the Literature

154 11 140KB

From the Literature

147 67 189KB

From the Literature

170 84 122KB

From the Literature

162 18 145KB

From the World Literature

169 111 105KB

From Literature to Cultural Literacy

181 25 3MB

Is the literature inconclusive about the harm from HES? No

172 110 919KB

The Legacy of Courtly Literature From Medieval to Contemporary Cultu

201 39 3MB

Benefitting from the Grey Literature in Software Engineering Research

167 55 13MB

Utopian Literature and Science From the Scientific Revolution to Bra

186 108 1MB